Skip to content
Human saphenous vein endothelial cells (HSVEC)
Tissue
Saphenous vein
Disease
Normal saphenous vein endothelium (primary cells; non-tumorigenic)
Metastatic site
Not applicable (normal, non-tumorigenic primary cell)
Synonyms
HSaVEC, HSVEC, Human saphenous vein endothelial cells, provitro 1210121

Documents

Human saphenous vein endothelial cells (HSVEC)

Primary cell · Product number 300699

Venous endothelium for bypass graft research

€1,220.00excl. tax and shipping

Customization / Recommendations

Made to order
1

01General information

Description

Primary Human Saphenous Vein Endothelial Cells (HSaVEC) are isolated from the saphenous vein and offer a venous endothelial model alongside HUVEC. They are used in research on atherosclerosis, leukocyte adhesion and the endothelial failure of coronary bypass vein grafts.

HSaVEC show the typical cobblestone morphology and express CD31 and VE-cadherin. As cells from adult vessels, they differ from fetal HUVEC: they are more sensitive to oxidized LDL, respond less strongly to cytokines and can present antigen to T cells, making them a closer model of adult venous endothelium.

Tissue
Saphenous vein
Disease
Normal saphenous vein endothelium (primary cells; non-tumorigenic)
Metastatic site
Not applicable (normal, non-tumorigenic primary cell)
Applications
Adult endothelial model: ox-LDL, leukocyte adhesion, antigen presentation and tumor cell adhesion; Endothelial dysfunction in coronary bypass patients, screening of interventions; Mechanobiology: shear stress and arterial-level stretch in vein graft arterialization; Oxidative stress and mitophagy in vein graft failure; Insulin and IGF-1 receptor signaling in type 2 diabetes; Biomaterials: bioactive wound dressings for chronic wounds
Synonyms
  • HSaVEC
  • HSVEC
  • Human saphenous vein endothelial cells
  • provitro 1210121

02Donor

Donor age
Lot-specific (see CoA)
Ethnicity
Lot-specific (see CoA)

03Classification

Organism
Human
Sex
Lot-specific
Growth properties
Adherent
GMO status
Non-GMO
GMO status details
No genetic modification; primary human endothelial cells isolated from saphenous vein tissue. Not transformed or immortalized.
Biosafety level
1

04Characteristics

Morphology
Cobblestone (endothelial)
Cell type
Primary endothelial cells
Tumourigenic
No
Doubling time
approx. 24 hours (under optimal EGM-2/EBM-2 conditions, Marelli-Berg et al. 2004)

05Handling and culture

Culture medium
Endothelial Cell Growth Medium
Incubation atmosphere

37°C, 5% CO2, saturated humidity.

Supplements
EGM-2-MV BulletKit supplements: hEGF, VEGF, hFGF-B, IGF-1, hydrocortisone, ascorbic acid, heparin, and 5% FBS (pre-formulated in EGM-2; no additional serum needed). Gelatin-coat culture vessels before seeding.
Dissociation reagent
Subculture reagents as recommended on the certificate of analysis
Flask coating
0.1–0.2% gelatin coating required (incubate gelatin solution 30 min at 37°C, aspirate excess before seeding)
Subculturing

Subculture the cells at about 75 % confluence. Denser cultures undergo irreversible contact inhibition and stop proliferating. Use the subculture reagents recommended on the certificate of analysis.

Split ratio
1 to 3
Seeding density
More than 6,000 cells/cm²
Fluid renewal
24 hours after seeding, then every 48 to 72 hours
Post-thaw recovery

Post-thaw viability ≥ 70 % viable cells. More than 80 % confluence within the expected recovery period.

Thawing and culturing
  1. Thaw the cryovial quickly in a 37 °C water bath, swirling gently. Just before the last ice has melted, move the vial to a laminar flow hood and decontaminate its outer surface.

  2. Transfer the cell suspension into a 15 ml centrifuge tube, add 10 ml of Endothelial Cell Growth Medium and centrifuge at 250 × g for 5 minutes.

  3. Remove the supernatant and resuspend the cell pellet in 10 ml of Endothelial Cell Growth Medium. Check cell number and viability.

  4. Divide the suspension between two 25 cm² culture flasks (5 ml each). Using two flasks reduces the risk of losing all cells if a passage fails.

  5. Incubate at 37 °C, 5 % CO₂ and saturated humidity, with the screw caps opened by half a turn for gas exchange.

  6. Change the medium after 24 hours to remove unattached cells, then every 48 to 72 hours, using pre-warmed medium only.

  7. Subculture the cells at about 75 % confluence. Denser cultures undergo irreversible contact inhibition and stop proliferating. Use the subculture reagents recommended on the certificate of analysis.

  8. Recommended seeding density: more than 6,000 cells/cm².

06Quality control and cryopreservation

Sterility

Mycoplasma contamination is excluded by PCR.

To ensure there is no bacterial, fungal or yeast contamination, cultures are subjected to visual inspection.

Freeze medium
As a cryopreservation medium, we use complete growth medium + 10% DMSO for adequate post-thaw viability.
Storage conditions

For long-term preservation, store vials in liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable for up to one week only.

Shipping conditions

Cryopreserved primary cells are shipped on dry ice. On receipt, check the cryovial for damage and transfer it without delay to appropriate storage.

07Expression and susceptibility

Surface antigens
CD31 (PECAM-1); VE-cadherin (CD144); von Willebrand factor (vWF); eNOS; HLA-DR (inducible); ICAM-1 (inducible); VCAM-1 (inducible); E-selectin (inducible); UEA-I lectin binding
Receptors expressed
VEGFR2 (KDR); VEGFR1; TIE-2; EGFR (low)

08Identifiers

Citation
Human saphenous vein endothelial cells (HSVEC) (Cytion catalog number 300699)
NCBI TaxID
9606
Cellosaurus
Not assigned